Trials / Sponsors / Codiak BioSciences
Codiak BioSciences
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Study of exoASO-STAT6 (CDK-004) in Patients With Advanced Hepatocellular Carcinoma (HCC) and Patients With L Advanced Hepatocellular Carcinoma (HCC), Gastric Cancer Metastatic to Liver, Colorectal Cancer Metastatic to Liver | Phase 1 | 2022-06-28 |
| Terminated | A Phase 1/2a Study of CDK-003 in Patients With Cutaneous T-Cell Lymphoma (CTCL). Cutaneous T-cell Lymphoma (CTCL) | Phase 1 | 2021-09-06 |
| Completed | A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Advanced Solid Tumor | Phase 1 / Phase 2 | 2020-09-15 |